We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGN Argenica Therapeutics Limited

0.00 (0.00%)
26 Feb 2024 - Closed
Delayed by 20 minutes

Argenica Therapeutics Financial Summary

The current AGN market cap is 55.72M. The company's latest EPS is AUD -0.0484 and P/E is -11.57.

Year End 30 June 2023 20202020202120222023
Total Revenue 00296k259k1.75M
Operating Income -383k0-614k-4.09M-4.88M
Net Income -383k0-1.03M-4.09M-4.82M
Year End 30 June 2023 20202020202120222023
Total Assets 378k7.52M7.27M9.04M9.54M
Total Liabilities 359k58k426k736k1.88M
Total Equity 19k7.46M6.85M8.31M7.67M

Cash Flow

Year End 30 June 2023 20202020202120222023
Operating -59k N/A -1.05M-3.36M-3.3M
Investing N/A N/A N/A N/A -50k
Financing 401k N/A 7.85M5.13M3.73M
Market Cap 55.72M
Price to Earnings Ratio -11.57
Price to Sales Ratio 31.82
Price to Cash Ratio 6
Price to Book Ratio 7.27
Dividend Yield -

Share Statistics

Shares Outstanding 99.5M
Average Volume (1 week) 38.38k
Average Volume (1 Month) 88.98k
52 Week Change 28.74%
52 Week High 0.68
52 Week Low 0.295
Spread (Intraday) 0.01 (1.79%)

Company Info

Company Name Argenica Therapeutics Limited
Address unit 4
nedlands, western australia 6009
Website https://
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |